Merger • Life Science

ProtaGene Acquires GeneWerk

On July 1, 2021, ProtaGene acquired life science company GeneWerk

Acquisition Context

This is ProtaGene’s 1st transaction in the Life Science sector.
This is ProtaGene’s 1st transaction in Germany.

Explore All 191 Merger Life Science Deals - Search the Database Free

M&A Deal Summary
Date	July 1, 2021
Target	GeneWerk
Sector	Life Science
Buyer(s)	ProtaGene
Deal Type	Merger

Target Company

GeneWerk

Heidelberg, Germany

GeneWerk is a provider of cell and gene therapy sponsors with patient testing services in compliance with guidance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). GeneWerk was founded in 2014 and is based in Heidelberg, Germany.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

ProtaGene

Heilbronn, Germany

Category	Company
Founded	1997
Sector	Life Science

DESCRIPTION

ProtaGene is a global contract research organization (CRO) dedicated to advanced analytics for biologics and cell and gene therapies. ProtaGene was founded in 1997 and is based in Heilbronn, Germany.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Merger	1 of 1
Country: Germany	1 of 1
Year: 2021	1 of 1

Explore Related M&A Activity

Life Science M&A - Merger M&A Deals - Germany M&A - 2021 M&A